[go: up one dir, main page]

WO2016191835A1 - Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound - Google Patents

Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound Download PDF

Info

Publication number
WO2016191835A1
WO2016191835A1 PCT/BR2015/050068 BR2015050068W WO2016191835A1 WO 2016191835 A1 WO2016191835 A1 WO 2016191835A1 BR 2015050068 W BR2015050068 W BR 2015050068W WO 2016191835 A1 WO2016191835 A1 WO 2016191835A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
called
reaction
heptane
give
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BR2015/050068
Other languages
French (fr)
Portuguese (pt)
Inventor
Luiz Francisco Pianowski
Lech W. Dudycz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amazonia Fitomedicamentos Ltda
Original Assignee
Amazonia Fitomedicamentos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amazonia Fitomedicamentos Ltda filed Critical Amazonia Fitomedicamentos Ltda
Priority to PCT/BR2015/050068 priority Critical patent/WO2016191835A1/en
Publication of WO2016191835A1 publication Critical patent/WO2016191835A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/20Polycyclic condensed hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/20Polycyclic condensed hydrocarbons
    • C07C15/38Polycyclic condensed hydrocarbons containing four rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/48Preparation of compounds having groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G8/00Condensation polymers of aldehydes or ketones with phenols only
    • C08G8/28Chemically modified polycondensates
    • C08G8/30Chemically modified polycondensates by unsaturated compounds, e.g. terpenes

Definitions

  • the present invention relates to the method of preparing ingenol-5,20-acetonide as well as ingenol-5,20-acetonide obtained by such a process.
  • the invention also relates to novel intermediate compounds of the ingenol-5,20-acetonide preparation.
  • ingenol-5,20-acetonide An example prior art synthesis of ingenol-5,20-acetonide is shown in patent application WO2012010172, wherein the ingenol compound (CAS # 30220-46-3) is reacted with acetone in the presence of p-toluenesulfonic acid. catalyst followed by neutralization with sodium hydrogen carbonate.
  • acetonide is an intermediate in obtaining ingenol-3-angelate, having ingenol as the starting material. This process is unsuitable for scale-up, especially as it cannot prevent a large loss of the precious ingenol raw material in the reaction of obtaining ingenol-5,20-acetonide from ingenol.
  • the present invention aims at a state of the art process optimized for obtaining ingenol-5,20-acetonide, particularly suitable for industrial scale production.
  • Cryogenic conditions in the following context, unless otherwise stated, refer to typical temperatures between -40 ° C and -80 ° C, and use of suitable equipment for this purpose.
  • the present invention aims at obtaining ingenol-5,20-acetonide from the reaction between 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde (hereinafter as compound 9) and 2,2-dimethyl-4-ethynyl-5-triphenylphosphoranylidene-1,3-dioxane (hereinafter referred to as compound 19), illustrated below:
  • the synthesis of the ingenol-5,20-acetonide compound from compounds 9 and 19 involves a sequence of Wittig reactions, Pauson-Khand cyclization, alkene oxidation, Grignard reaction and a rearrangement of Pinacol.
  • Step 1 is a Wittig reaction, also called Wittig olefination, in which compound 9, an aldehyde, reacts with compound 19, a phosphorus ylide called Wittig reagent in organic solution at a high temperature of the order 100 ° C in the presence of strong bases, for example potassium tert-butoxide.
  • An alkene - intermediate 1 - and triphenylphosphine oxide to be removed are obtained. Ilet instability results in high prevalence of alkene - ie intermediate 1 - of Z configuration.
  • This ring formation step is a addition [2 + 2 + 1] between intermediate 1, an alkene, and carbon monoxide, in the presence of a suitable catalyst, for example a transition metal complex such as dicobalt octacarbonyl Co 2 (CO) 8 , under atmospheric pressure of CO.
  • a suitable catalyst for example a transition metal complex such as dicobalt octacarbonyl Co 2 (CO) 8 , under atmospheric pressure of CO.
  • This step refers to a dihydroxylation of intermediate 2, which can be done in alternate ways:
  • Os0 4 osmium tethoxide
  • periodate particularly metaperiodate, or potassium peroxymonosulfate (eg Oxone ® marketed by Dupont de Nemours), in the presence of ruthenium or cerium catalyst under neutral conditions.
  • periodate particularly metaperiodate, or potassium peroxymonosulfate (eg Oxone ® marketed by Dupont de Nemours)
  • ruthenium or cerium catalyst under neutral conditions.
  • Intermediate 3 is identified as (1R, 5R, 6R, 7R, 14S, 15R, 17R, 19R) -1,5,6-trihydroxy-1 H, and g-pentamethyl-S 2 O-dioxapentacyclothiazol. O, 1 .0 2 ⁇ , 2.12 ⁇ nonadeca-dien-4-one.
  • Intermediate 4 is identified as (1S, 2R, 9S, 10R, 12R, 14R, 15R, 19R) -15-hydroxy-4,4, H, 11,14-pentamethyl-3,5,20,22-tetraoxahexacyclo [ 14.6.0.0 1, 1 .0 2 .0, 1 1 .0 12] docosahexaenoic 18,21-diene-7,16-dione.
  • Step 4 relates to methylation of the cyclopentenone ring with a Grignard reagent, methyl magnesium bromide under cryogenic conditions. This reaction turns ketone on carbon 2 into tertiary alcohol, yielding intermediate 5 of tiglian structure.
  • Step 5 is a pinacol rearrangement, in which tertiary alcohol loses the hydroxyl group, generating a carbo-cation at position 2.
  • the arrows in the image of intermediate 5 above indicate the parts involved in the transformation.
  • the reaction is catalyzed, for example, with boron trifluoride etherate, organoaluminum compounds or any other suitable one.
  • Step 3 Removal of the useful diol protection introduced in step 3 by any suitable means, for example by using a base, TBAF (tetrabutylammonium fluoride) or pyridinium hydrofluoride.
  • TBAF tetrabutylammonium fluoride
  • pyridinium hydrofluoride tetrabutylammonium fluoride
  • the present invention further relates to the synthesis of compound 9 used in the synthesis of ingenol-5,20-acetonide described above.
  • the reaction of this step is itself known, for example described in Polish J. Chem. 74, 777, 2000, using free radical catalyst such as N-chloro-succinamide (NCS) in the presence of base under argon atmosphere.
  • NCS N-chloro-succinamide
  • the catalyst base may be 1,4-diazabicyclo [2.2.2] octane (as the DABCO ® commercial product of Air Products), DMAP (4-dimethylaminopyridine), or silica gel.
  • compound 2 is ozonolysis in a suitable solvent, particularly aqueous acetone, under cooling.
  • This step is a reductive catalytic dechlorination.
  • Compound 4 (7,7-dimethylbicyclo [4.1.0] heptane-3-one) is obtained by catalytic hydrogenolysis of compound 3 using a suitable catalyst, for example palladium, under pressure.
  • a suitable catalyst for example palladium, under pressure.
  • the resulting hydrogen chloride may be collected in situ by carbonate salts.
  • Compound 5 This step refers to the hydroxymethylation of compound 5 to give compound 6 (2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one).
  • the reaction is also known, for example as disclosed in the aforementioned article by A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), performed with formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III).
  • Compound 7 (2-hydroxymethyl-4,7,7-trimethylbicyclo [4.1.0] heptane-3-one) is obtained by methylation of compound 6, initiated by the transient protective reaction of compound 6 with trimethylsilyl chloride (TMS), TMS enol formation, lithium enol lithium, and subsequent reaction in a vessel with methyl iodate under cryogenic conditions at a temperature of -78 ° C.
  • TMS trimethylsilyl chloride
  • Compound 9 is obtained by reacting compound 8 with 1,1,1-triacetoxy-1,1-dihydro-1,2-benziodoxol-3 (1H) -one, the Dess-Martin periodinane reagent.
  • steps 3A, 4A, 5A and 6A described above may be replaced by steps 3AA, 4AA and 5AA described below.
  • Compound 3 is transformed into Grignard reagent using magnesium followed by reaction with methyl iodide, with or without catalyst, for example NiBr 2 or CuCl 2 to give compound 10, which is 4-methyl-7, 7-dimethylbicyclo [4.1.0] heptane-3-one.
  • Compound 11 which is 4-methyl-5-trimethylsilyl 7,7-dimethylbicyclo [4.1.0] -2-hepten-3-ol, a TMS enol, is prepared in a suitable solvent, such as THF, in reaction. of compound 10 with TMS and lithium bis (trimethylsilyl) amide chloride (LiHDMS) under cryogenic conditions at a temperature of -78 ° C.
  • a suitable solvent such as THF
  • This step refers to the hydroxymethylation of compound 11 to yield compound 7 (2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one).
  • the reaction is also known, for example as disclosed in the aforementioned article by A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), performed with formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III).
  • the present invention further relates to the synthesis of compound 19, used in the synthesis of ingenol-5,20-acetonide, described above.
  • Compound 19 is obtained from L-serine methyl ester (N-methyl-L-serine).
  • compound 13 is reacted with DIBAL (diisobutylaluminum hydride) resulting in compound 14: 3-Boc-2,2-dimethyl-1,3-oxazolidine-4-formyl.
  • DIBAL diisobutylaluminum hydride
  • compound 13 is subjected to reduction, for example with lithium aluminum hydride or lithium borohydride, followed by oxidation, for example Swern oxidation, or via the use of a suitable bleach such as sodium or calcium hypochlorite, in the presence of catalyst TEMPO (2,2,6,6-tetramethylpiperidinyloxy, CAS No 2564-83-2), resulting compound 14.
  • TEMPO 2,2,6,6-tetramethylpiperidinyloxy, CAS No 2564-83-2
  • This step is aimed at deprotecting compound 15 to generate compound 16, which is (2S, 3S) -2-amino-1,3-dihydroxy-pent-4-yo, occurs in the presence of aqueous TFA (trifluoroacetic acid) or inorganic acids such as HCl or HBr.
  • TFA trifluoroacetic acid
  • HCl HCl
  • HBr HBr
  • Aqueous solution of compound 16 is diazotized in the presence of HBr and KBr to obtain compound 17: (2S, 3S) -2-bromo-1,3-dihydroxy-pent-4-yn.
  • the amino group is initially converted to the diazo moiety, which in turn is readily displaced by bromine anions.
  • Compound 17 is recovered by extraction in organic solvents.
  • Compound 17 is dissolved in a suitable solvent, for example mixture of acetone and 2,2-dimethoxypropane and treated with catalytic amount of sulfonic acid or BF 3 etherate, resulting in compound 18: (2S, 3S) -2-bromo-1,3 -dihydroxy-pent-4-yne acetonide.
  • a suitable solvent for example mixture of acetone and 2,2-dimethoxypropane and treated with catalytic amount of sulfonic acid or BF 3 etherate, resulting in compound 18: (2S, 3S) -2-bromo-1,3 -dihydroxy-pent-4-yne acetonide.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a method for preparing ingenol-5,20-acetonide, and to the ingenol-5,20-acetonide obtained by this method. The invention is also directed to new intermediate compounds for the preparation of ingenol-5,20-acetonide.

Description

MÉTODO DE PREPARAÇÃO DE INGENOL-5,20-ACETONIDA, MÉTODO DE PREPARAÇÃO DE 3-ETINIL-3-HIDROXI-4.7.7-TRIMETILBICICLO[4.1.0] HEPTANO-2- CARBALDEÍDO, MÉTODO DE PREPARAÇÃO DO COMPOSTO 2,2-DIMETIL-4-ETINIL-5 - TRIFENILFOSFORANILIDENO-l,3-DIOXANO E COMPOSTO INTERMEDIÁRIO  INGENOL-5,20-ACETONIDE PREPARATION METHOD, 3-ETHINYL-3-HYDROXI-4.7.7-TRIMETHYLBICICLE PREPARATION METHOD [4.1.0] HEPTAN-2-CARBALDEIDE, COMPOSITE PREPARATION METHOD 2,2-DIMETHYL -4-ETINYL-5 - TRYPHENYLPHOSPHORANYLIDEN-1,3-DIOXANE AND INTERMEDIATE COMPOUND

A presente invenção refere-se a método de preparação de ingenol-5,20- acetonida, assim como ingenol-5,20-acetonida obtida por tal processo. A invenção visa também novos compostos intermediários da preparação de ingenol-5,20- acetonida.  The present invention relates to the method of preparing ingenol-5,20-acetonide as well as ingenol-5,20-acetonide obtained by such a process. The invention also relates to novel intermediate compounds of the ingenol-5,20-acetonide preparation.

Antecedentes da Invenção  Background of the Invention

lngenol-5,20-acetonida, ilustrada abaixo, identificada pelo número CAS 77573- lngenol-5,20-acetonide, illustrated below, identified by CAS number 77573-

43-4, é composto conhecido como intermediário na síntese de derivados 3-ester de ingenol, entre outras aplicaçõe gem mais longa que ingenol. 43-4, is a compound known as an intermediate in the synthesis of ingenol 3-ester derivatives, among other applications longer than ingenol.

Figure imgf000002_0001
Figure imgf000002_0001

Ingenol-5,20-acetonida Ingenol-5,20-acetonide

Um exemplo de síntese de ingenol-5,20-acetonida do estado da técnica é mostrado no pedido de patente WO2012010172, em que o composto ingenol (no. CAS 30220-46-3) é reagido com acetona em presença de ácido p-toluenosulfônico catalisador, seguindo-se neutralização com hidrogenocarbonato de sódio. No contexto daquele documento, a acetonida é um intermediário na obtenção de ingenol-3- angelato, tendo ingenol como material de partida. Esse processo é inadequado a um aumento de escala, principalmente por não conseguir evitar uma grande perda da preciosa matéria prima ingenol na reação de obtenção de ingenol-5,20-acetonida a partir de ingenol.  An example prior art synthesis of ingenol-5,20-acetonide is shown in patent application WO2012010172, wherein the ingenol compound (CAS # 30220-46-3) is reacted with acetone in the presence of p-toluenesulfonic acid. catalyst followed by neutralization with sodium hydrogen carbonate. In the context of that document, acetonide is an intermediate in obtaining ingenol-3-angelate, having ingenol as the starting material. This process is unsuitable for scale-up, especially as it cannot prevent a large loss of the precious ingenol raw material in the reaction of obtaining ingenol-5,20-acetonide from ingenol.

A presente invenção visa um processo otimizado em relação ao estado da técnica, voltado à obtenção de ingenol-5,20-acetonida, particularmente adequado à produção em escala industrial. The present invention aims at a state of the art process optimized for obtaining ingenol-5,20-acetonide, particularly suitable for industrial scale production.

Descrição da Invenção Description of the Invention

Condições criogênicas, no contexto que segue, exceto menção em contrário, refere-se a temperaturas típicas entre -40°C e -80°C, e utilização de equipamentos adequados para esse fim.  Cryogenic conditions, in the following context, unless otherwise stated, refer to typical temperatures between -40 ° C and -80 ° C, and use of suitable equipment for this purpose.

A presente invenção visa a obtenção de ingenol-5,20-acetonida a partir da reação entre 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0]heptano-2-carbaldeído (a seguir referido como composto 9) e 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-l,3- dioxano (a seguir referido como composto 19), ilustrados abaixo:  The present invention aims at obtaining ingenol-5,20-acetonide from the reaction between 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde (hereinafter as compound 9) and 2,2-dimethyl-4-ethynyl-5-triphenylphosphoranylidene-1,3-dioxane (hereinafter referred to as compound 19), illustrated below:

Figure imgf000003_0001
Figure imgf000003_0001

Composto 9 Composto 19 Compound 9 Compound 19

Em um primeiro aspecto da invenção, a síntese do composto ingenol-5,20- acetonida a partir dos compostos 9 e 19 envolve uma sequência das reações de Wittig, ciclização de Pauson-Khand, oxidação de alceno, reação de Grignard e um rearranjo de pinacol. In a first aspect of the invention, the synthesis of the ingenol-5,20-acetonide compound from compounds 9 and 19 involves a sequence of Wittig reactions, Pauson-Khand cyclization, alkene oxidation, Grignard reaction and a rearrangement of Pinacol.

A descrição a seguir ilustra um primeiro aspecto da invenção, qual seja, as etapas de obtenção de ingenol-5,20-acetonida a partir dos compostos 9 e 19 mencionados acima.  The following description illustrates a first aspect of the invention, namely the steps of obtaining ingenol-5,20-acetonide from the above mentioned compounds 9 and 19.

Mais adiante serão descritos outros aspectos da invenção, quais sejam, as sínteses de tais compostos 9 e 19 a partir de matérias primas adequadas quanto à disponibilidade comercial abundante e baixo custo, respectivamente (+) 3-careno e metil serina.  Further aspects of the invention will be described below, such as syntheses of such compounds 9 and 19 from suitable starting materials for abundant commercial availability and low cost, respectively (+) 3-carene and methyl serine.

Etapa 1 COMPOSTO 9 + COMPOSTO 19 Step 1 9 + 9

Figure imgf000004_0001
Figure imgf000004_0001

Intermediário 1 Intermediate 1

A etapa 1 é uma reação de Wittig, também chamada de olefinação de Wittig, em que o composto 9, um aldeído, reage com o composto 19, um ileto de fósforo, chamado reagente de Wittig, em solução orgânica, em temperatura alta da ordem de 100°C, em presença de bases fortes, por exemplo terc-butóxido de potássio. Obtém-se um alceno - o intermediário 1 - e óxido de trifenilfosfina, a ser eliminada. A instabilidade do ileto resulta em grande prevalência de alceno - ou seja, o intermediário 1 - de configuração Z.  Step 1 is a Wittig reaction, also called Wittig olefination, in which compound 9, an aldehyde, reacts with compound 19, a phosphorus ylide called Wittig reagent in organic solution at a high temperature of the order 100 ° C in the presence of strong bases, for example potassium tert-butoxide. An alkene - intermediate 1 - and triphenylphosphine oxide to be removed are obtained. Ilet instability results in high prevalence of alkene - ie intermediate 1 - of Z configuration.

O intermediário 1 é identificado como (lR,2R,3R,4R,6R)-3-ethinil-2-{l-[(4S,5Z)- Intermediate 1 is identified as (1R, 2R, 3R, 4R, 6R) -3-ethinyl-2- {1 - [(4S, 5Z) -

4-ethinil-2,2-dimetil-l,3-dioxan-5-ilideno] etil}-4.7.7-trimetilbiciclo[4.1.0]heptan-3-ol. 4-ethinyl-2,2-dimethyl-1,3-dioxan-5-ylidene] ethyl} -4.7.7-trimethylbicyclo [4.1.0] heptan-3-ol.

Figure imgf000004_0002
Figure imgf000004_0002

Intermediário 1 Intermediário 2 Intermediate 1 Intermediate 2

Esta etapa de formação de anel, uma reação de Pauson-Khand, é uma ciclo- adição [2+2+1] entre o intermediário 1, um alceno, e monóxido de carbono, em presença de catalisador adequado, por exemplo um complexo de metal de transição como dicobalto octacarbonila Co2(CO)8, sob pressão de atmosfera de CO. This ring formation step, a Pauson-Khand reaction, is a addition [2 + 2 + 1] between intermediate 1, an alkene, and carbon monoxide, in the presence of a suitable catalyst, for example a transition metal complex such as dicobalt octacarbonyl Co 2 (CO) 8 , under atmospheric pressure of CO.

O intermediário 2 é identificado como (lR,7S,14S,15R,17R,19R)-l-hidroxi- 9,9,16,16,19-pentametil-8,10-dioxapentaciclo[12.5.0.02,.0,12.0V] nonadeca-2,5,12- trien-4-ona. Intermediate 2 is identified as (1R, 7S, 14S, 15R, 17R, 19R) -1-hydroxy-9,9,16,16,19-pentamethyl-8,10-dioxapentacyclo [12.5.0.0 2 , .0, 12 .0V] nonadeca-2,5,12- trien-4-one.

Etapa 3 Step 3

Figure imgf000005_0001
Figure imgf000005_0001

Intermediário 2 Intermediário 3 Intermediate 2 Intermediate 3

Esta etapa refere-se a uma diidroxilação do intermediário 2, que pode ser feita de maneiras alternativas:  This step refers to a dihydroxylation of intermediate 2, which can be done in alternate ways:

- via uma reação de osmilação, catalisada com tetróxido de ósmio (Os04), por exemplo em solução ou suportado em um polímero; via an osmylation reaction, catalyzed with osmium tethoxide (Os0 4 ), for example in solution or supported on a polymer;

- via reação com periodato, particularmente metaperiodato, ou peroximonosulfato de potássio (por exemplo Oxone® comercializado por Dupont de Nemours), em presença de catalisador de rutênio ou cério sob condições neutras. - via reaction with periodate, particularly metaperiodate, or potassium peroxymonosulfate (eg Oxone ® marketed by Dupont de Nemours), in the presence of ruthenium or cerium catalyst under neutral conditions.

A subsequente proteção dos dióis eis, mostrada abaixo, é efetuada utilizando bis-imidazolil carbonato ou reagentes sililantes. Subsequent protection of useful diols, shown below, is performed using bisimidazolyl carbonate or silylating reagents.

Figure imgf000006_0001
Figure imgf000006_0001

Intermediário 3 Intermediário 4Intermediate 3 Intermediate 4

O intermediário 3 é identificado como (1R,5R,6R,7R,14S,15R,17R,19R)-1,5,6- triidroxi-^^ie^e g-pentametil-S^O-dioxapentaciclotlZ.S.O.O^.O,1 2.0Ί , ^nonadeca- 2,12-dien-4-ona. Intermediate 3 is identified as (1R, 5R, 6R, 7R, 14S, 15R, 17R, 19R) -1,5,6-trihydroxy-1 H, and g-pentamethyl-S 2 O-dioxapentacyclothiazol. O, 1 .0 2 Ί, 2.12 ^ nonadeca-dien-4-one.

O intermediário 4 é identificado como (1S,2R,9S,10R,12R,14R,15R,19R)-15- hidroxi-4,4,H,ll,14-pentametil-3,5,20,22-tetraoxahexaciclo[14.6.0.01,1.02,.0,1.01,12] docosa-7,16-dieno-18,21-diona. Intermediate 4 is identified as (1S, 2R, 9S, 10R, 12R, 14R, 15R, 19R) -15-hydroxy-4,4, H, 11,14-pentamethyl-3,5,20,22-tetraoxahexacyclo [ 14.6.0.0 1, 1 .0 2 .0, 1 1 .0 12] docosahexaenoic 18,21-diene-7,16-dione.

Etapa 4  Step 4

Figure imgf000006_0002
Figure imgf000006_0002

Intermediário 4 Intermediário 5 Intermediate 4 Intermediate 5

A etapa 4 refere-se à metilação do anel ciclopentenona com um reagente de Grignard, brometo de metil magnésio sob condições criogênicas. Esta reação transforma a cetona no carbono 2 em álcool terciário, originando o intermediário 5 de estrutura de tigliano. Step 4 relates to methylation of the cyclopentenone ring with a Grignard reagent, methyl magnesium bromide under cryogenic conditions. This reaction turns ketone on carbon 2 into tertiary alcohol, yielding intermediate 5 of tiglian structure.

O intermediário 5 é identificado como (1S,2R,9S,10R,12R,14R,15R,18R,19S)- 15,18-diidroxi-4,4,ll,ll,14,18-hexametil-3,5,20,22-tetraoxahexaciclo  Intermediate 5 is identified as (1S, 2R, 9S, 10R, 12R, 14R, 15R, 18R, 19S) -15,18-dihydroxy-4,4,11,11,11,18-hexamethyl-3,5, 20,22-tetraoxahexacyclo

[14.6.0.01,1.02,.0,1.01,12] docosa-7,16-dien-21-ona. Etapa 5 [14.6.0.0 1, 1 .0 2 .0, 1 1 .0 12] docosahexaenoic 7,16-dien-21-one. Step 5

Figure imgf000007_0001
Figure imgf000007_0001

Intermediário 5 Intermediário 6 Intermediate 5 Intermediate 6

A etapa 5 é um rearranjo de pinacol, em que o álcool terciário perde o grupo hidroxila, gerando uma carbo-cátion na posição 2. As setas na imagem do intermediário 5 acima indicam as partes envolvidas na transformação. A reação é catalisada, por exemplo, com trifluoreto de boro eterato, compostos de organoalumínio ou qualquer outro adequado.  Step 5 is a pinacol rearrangement, in which tertiary alcohol loses the hydroxyl group, generating a carbo-cation at position 2. The arrows in the image of intermediate 5 above indicate the parts involved in the transformation. The reaction is catalyzed, for example, with boron trifluoride etherate, organoaluminum compounds or any other suitable one.

O intermediário 6 é identificado como (1S,4S,8S,9R,16S,17R,19R,21R)- 3,ll,ll,18,18,21-hexametil-5,7,10,12-tetraoxahexaciclo[14.5.1.01,.0,.0,1.0V]docosa-Intermediate 6 is identified as (1S, 4S, 8S, 9R, 16S, 17R, 19R, 21R) -3,11,11,18,18,21-hexamethyl-5,7,10,12-tetraoxahexacyclo [14.5. 1.0 1 .0, .0, 1 .0V] docosahexaenoic

2,14-dieno-6,22-diona. 2,14-diene-6,22-dione.

Etapa 6  Step 6

Trata-se da remoção da proteção aos dióis eis, introduzida na etapa 3, por qualquer meio adequado, por exemplo empregando-se uma base, TBAF (fluoreto de tetrabutilamônio) ou hidrofluoreto de piridínio.  Removal of the useful diol protection introduced in step 3 by any suitable means, for example by using a base, TBAF (tetrabutylammonium fluoride) or pyridinium hydrofluoride.

Figure imgf000007_0002
Figure imgf000007_0002

Intermediário 6 ingenol-5,20-acetonida Dentro de aspecto adicional, a invenção refere-se aos compostos intermediários numerados de 1 a 6, dentro da sequência de etapas de obtenção ingenol-5,20-acetonida, retro-descritas. Intermediate 6 ingenol-5,20-acetonide In a further aspect, the invention relates to intermediate compounds numbered from 1 to 6 within the sequence of ingenol-5,20-acetonide obtaining steps described above.

Obtenção do Composto 9 Obtaining Compound 9

A presente invenção refere-se adicionalmente à síntese do composto 9, utilizado na síntese de ingenol-5,20-acetonida, já descrita mais atrás.  The present invention further relates to the synthesis of compound 9 used in the synthesis of ingenol-5,20-acetonide described above.

Figure imgf000008_0001
Figure imgf000008_0001

Composto 1 Composto 2 Compound 1 Compound 2

Trata-se de uma etapa de cloração do (+)-3- careno (composto 1), obtendo-se trans-4-cloro-3-careno (composto 2). A reação desta etapa é em si conhecida, por exemplo descrita em Polish J. Chem. 74, 777, 2000, utilizando catalisador de radicais livres, como N-cloro-succinamida (NCS) em presença de base, sob atmosfera de argônio.  This is a chlorination step for (+) -3-carene (compound 1) to give trans-4-chloro-3-carene (compound 2). The reaction of this step is itself known, for example described in Polish J. Chem. 74, 777, 2000, using free radical catalyst such as N-chloro-succinamide (NCS) in the presence of base under argon atmosphere.

A base do catalisador pode ser l,4-diazabiciclo[2.2.2]octano (como o produto comercial DABCO®, da empresa Air Products), DMAP (4-dimetilaminopiridina), ou sílica gel. The catalyst base may be 1,4-diazabicyclo [2.2.2] octane (as the DABCO ® commercial product of Air Products), DMAP (4-dimethylaminopyridine), or silica gel.

Etapa 2A

Figure imgf000008_0002
Step 2A
Figure imgf000008_0002

Composto 2 Composto 3 Compound 2 Compound 3

Nesta etapa, para obtenção do composto 3, 4-cloro-7,7- dimetilbiciclo[4.1.0]heptano-3-ona), faz-se a ozonólise do composto 2, em solvente adequado, particularmente acetona aquosa, sob resfriamento.  In this step, to obtain compound 3,4-chloro-7,7-dimethylbicyclo [4.1.0] heptane-3-one), compound 2 is ozonolysis in a suitable solvent, particularly aqueous acetone, under cooling.

Eventuais peróxidos residuais são reagidos com dimetilsulfeto antes da remoção da acetona. Possible residual peroxides are reacted with dimethyl sulfide prior to acetone removal.

Etapa 3 A

Figure imgf000009_0001
Step 3 A
Figure imgf000009_0001

Composto 3 Composto 4 Compound 3 Compound 4

Esta etapa é uma descloração catalítica redutiva. O composto 4 (7,7- dimetilbiciclo[4.1.0]heptano-3-ona) é obtido por hidrogenólise catalítica do composto 3, empregando-se catalisador adequado, por exemplo de paládio, sob pressão. O cloreto de hidrogénio resultante pode ser recolhido in situ por sais de carbonato.  This step is a reductive catalytic dechlorination. Compound 4 (7,7-dimethylbicyclo [4.1.0] heptane-3-one) is obtained by catalytic hydrogenolysis of compound 3 using a suitable catalyst, for example palladium, under pressure. The resulting hydrogen chloride may be collected in situ by carbonate salts.

Etapa 4 Step 4

Figure imgf000009_0002
Figure imgf000009_0002

Composto 4 Composto 5 Compound 4 Compound 5

A reação de obtenção do composto 5 (trimetilsilil 7,7-dimetilbiciclo[4.1.0]2- hepteno-3-ol) a partir do composto 4 é, em sua generalidade, conhecida do estado da técnica, por exemplo o artigo de A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), utilizando cloreto de TMS (trimetilsilila) e lítio bis(trimetilsilil)amida (LiHMDS ) em tetraidrofurano (THF) em condições criogênicas, em temperatura da ordem de -78° C. Etapa 5 A The reaction of obtaining compound 5 (trimethylsilyl 7,7-dimethylbicyclo [4.1.0] 2-hepten-3-ol) from compound 4 is generally known in the art, for example the article in A Sekine et al. (Tetrahedron Letters 41 (2000) 509) using TMS (trimethylsilyl) and lithium bis (trimethylsilyl) amide (LiHMDS) chloride in tetrahydrofuran (THF) under cryogenic conditions at a temperature of -78 ° C. Step 5 A

Figure imgf000009_0003
Figure imgf000009_0003

Composto 5 Composto 6 Esta etapa refere-se à hidroximetilação do composto 5 para gerar o composto 6 (2-hidroximetil-7,7-dimetilbiciclo[4.1.0]heptano-3-ona). A reação é também conhecida, por exemplo como revelado no artigo já mencionado de A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), realizada com formaldeído em presença de Yb(OTf)3 (trifluorometanosulfonato de itérbio III). Compound 5 Compound 6 This step refers to the hydroxymethylation of compound 5 to give compound 6 (2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one). The reaction is also known, for example as disclosed in the aforementioned article by A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), performed with formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III).

Etapa 6A Step 6A

Figure imgf000010_0001
Figure imgf000010_0001

Composto 6 Composto 7 Compound 6 Compound 7

O composto 7 (2-hidroximetil-4.7.7-trimetilbiciclo[4.1.0]heptano-3-ona) é obtido por metilação do composto 6, iniciada com a reação de proteção transitória do composto 6 com cloreto de trimetilsilila (TMS), formação de TMS enol, litiação do enol com metil lítio, e subsequente reação em um vaso com metil iodato em condições criogênicas, em temperatura da ordem de -78°C.  Compound 7 (2-hydroxymethyl-4,7,7-trimethylbicyclo [4.1.0] heptane-3-one) is obtained by methylation of compound 6, initiated by the transient protective reaction of compound 6 with trimethylsilyl chloride (TMS), TMS enol formation, lithium enol lithium, and subsequent reaction in a vessel with methyl iodate under cryogenic conditions at a temperature of -78 ° C.

Etapa 7A Step 7A

Figure imgf000010_0002
Figure imgf000010_0002

Composto 7 Composto 8 Compound 7 Compound 8

O composto 8 (3-etinil-2-hiydroximetil-4.7.7-trimetilbiciclo [4.1.0] heptano-3-ol) é obtido reagindo-se o composto 7 com excesso de brometo de etinilmagnésio em solvente como THF em condições criogênicas, em temperatura da ordem de -78 C. Etapa 8A Compound 8 (3-ethynyl-2-hydroxymethyl-4,7,7-trimethylbicyclo [4.1.0] heptane-3-ol) is obtained by reacting compound 7 with excess ethinylmagnesium bromide in solvent as THF under cryogenic conditions, at a temperature of -78 ° C. Step 8A

Figure imgf000011_0001
Figure imgf000011_0001

Composto 8 Composto 9 Compound 8 Compound 9

A obtenção do composto 9 ocorre pela reação do composto 8 com 1,1,1- triacetoxi-l,l-diidro-l,2-benziodoxol-3(lH)-ona, o reagente de Dess-Martin periodinano.  Compound 9 is obtained by reacting compound 8 with 1,1,1-triacetoxy-1,1-dihydro-1,2-benziodoxol-3 (1H) -one, the Dess-Martin periodinane reagent.

De forma alternativa, as etapas 3A, 4A, 5A e 6A acima descritas podem ser substituídas pelas etapas 3AA, 4AA e 5AA, descritas a seguir.  Alternatively, steps 3A, 4A, 5A and 6A described above may be replaced by steps 3AA, 4AA and 5AA described below.

Etapa 3AA Step 3AA

Figure imgf000011_0002
Figure imgf000011_0002

Composto 3 Composto 10Compound 3 Compound 10

O composto 3 é transformado em reagente de Grignard utilizando-se magnésio, seguindo-se reação com iodeto de metila, com ou sem catalisador, por exemplo NiBr2 ou CuCI2, dando origem ao composto 10, que é 4-metil-7,7- dimetilbiciclo[4.1.0]heptano-3-ona. Compound 3 is transformed into Grignard reagent using magnesium followed by reaction with methyl iodide, with or without catalyst, for example NiBr 2 or CuCl 2 to give compound 10, which is 4-methyl-7, 7-dimethylbicyclo [4.1.0] heptane-3-one.

Etapa 4AA Step 4AA

Figure imgf000011_0003
Figure imgf000011_0003

Composto 10 Composto 11Compound 10 Compound 11

O composto 11, qual seja 4-metil-5-trimetilsilil 7,7-dimetilbiciclo[4.1.0]-2- hepteno-3-ol, um TMS enol, é preparado em solvente adequado, como THF, em reação do composto 10 com cloreto de TMS e lítio bis(trimetilsilil)amida (LiHDMS) em condições criogênicas, em temperatura da ordem de -78°C. Compound 11, which is 4-methyl-5-trimethylsilyl 7,7-dimethylbicyclo [4.1.0] -2-hepten-3-ol, a TMS enol, is prepared in a suitable solvent, such as THF, in reaction. of compound 10 with TMS and lithium bis (trimethylsilyl) amide chloride (LiHDMS) under cryogenic conditions at a temperature of -78 ° C.

Etapa 5AA Step 5AA

Figure imgf000012_0001
Composto 11 Composto 7
Figure imgf000012_0001
Compound 11 Compound 7

Esta etapa refere-se à hidroximetilação do composto 11 para gerar o composto 7 (2-hidroximetil-7,7-dimetilbiciclo[4.1.0]heptano-3-ona). A reação é também conhecida, por exemplo como revelado no artigo já mencionado de A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), realizada com formaldeído em presença de Yb(OTf)3 (trifluorometanosulfonato de itérbio III).  This step refers to the hydroxymethylation of compound 11 to yield compound 7 (2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one). The reaction is also known, for example as disclosed in the aforementioned article by A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), performed with formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III).

Obtenção do Composto 19 Obtaining Compound 19

A presente invenção refere-se adicionalmente à síntese do composto 19, utilizado na síntese de ingenol-5,20-acetonida, já descrita mais atrás  The present invention further relates to the synthesis of compound 19, used in the synthesis of ingenol-5,20-acetonide, described above.

A obtenção do composto 19 se dá a partir do éster metílico de L-serina (N- metil-L-serina).  Compound 19 is obtained from L-serine methyl ester (N-methyl-L-serine).

Obs: Boc = terc-butoxi carbonila  Note: Boc = tert-butoxy carbonyl

Etapa 1B Step 1B

Figure imgf000012_0002
Figure imgf000012_0002

Composto 12 Composto 13Compound 12 Compound 13

Reação do éster metílico de L-serina, denominado composto 12, com anidrido de terc-butoxi carbonila em presença de trietilamina, resultando éster metílico de Boc- L-serina, o qual, em solvente adequado, particularmente acetona, é reagido com 2,2- dimetoxipropano em presença de quantidade catalítica de trifluoreto de boro eterato, resultando o composto 13: 3-Boc-2,2-dimetil-l,3-oxazolidina-4-carboxilato Reaction of L-serine methyl ester, named compound 12, with anhydride of tert-butoxycarbonyl in the presence of triethylamine, resulting in Boc-L-serine methyl ester which, in a suitable solvent, particularly acetone, is reacted with 2,2-dimethoxypropane in the presence of catalytic amount of boron trifluoride etherate, resulting compound 13: 3-Boc-2,2-dimethyl-1,3-oxazolidine-4-carboxylate

Etapa 2B Step 2B

Figure imgf000013_0001
Figure imgf000013_0001

Composto 13 Composto 14Compound 13 Compound 14

O composto 13 é reagido com DIBAL (hidreto de diisobutilalumínio) resultando o composto 14: 3-Boc-2,2-dimetil-l,3-oxazolidina-4-formila. Alternativamente, submete-se o composto 13 a uma redução, por exemplo com hidreto de lítio alumínio ou boroidreto de lítio, seguida de oxidação, por exemplo uma oxidação de Swern, ou via uso de um alvejante adequado, como hipoclorito de sódio ou cálcio, em presença de catalisador TEMPO (2,2,6,6-tetrametilpiperidiniloxi, número CAS 2564-83-2 ), resultando o composto 14. Compound 13 is reacted with DIBAL (diisobutylaluminum hydride) resulting in compound 14: 3-Boc-2,2-dimethyl-1,3-oxazolidine-4-formyl. Alternatively, compound 13 is subjected to reduction, for example with lithium aluminum hydride or lithium borohydride, followed by oxidation, for example Swern oxidation, or via the use of a suitable bleach such as sodium or calcium hypochlorite, in the presence of catalyst TEMPO (2,2,6,6-tetramethylpiperidinyloxy, CAS No 2564-83-2), resulting compound 14.

Etapa 3B Step 3B

Figure imgf000013_0002
Figure imgf000013_0002

Composto 14 Composto 15Compound 14 Compound 15

Reação do composto 14 com brometo de magnésio acetileno ou lítio acetilida em meio solvente adequado, por exemplo, THF ou etil éter, preferivelmente conduzida sob condições criogênicas. Resulta um composto 15: Boc-(2S,3S)-2-Amino-1.3-diidroxi- pent-4-ina-l,2-acetal Reaction of compound 14 with magnesium acetylene bromide or lithium acetylide in a suitable solvent medium, for example THF or ethyl ether, preferably conducted under cryogenic conditions. A compound 15 is obtained: Boc- (2S, 3S) -2-Amino-1,3-dihydroxy- pent-4-yn-1,2-acetal

Etapa 4B Step 4B

Figure imgf000014_0001
Figure imgf000014_0001

Composto 15 Composto 16Compound 15 Compound 16

Esta etapa visa a desproteção do composto 15, para gerar o composto 16, qual seja (2S,3S)-2-amino-l,3-dihidroxi-pent-4-ino, ocorre em presença de TFA (ácido trifluoroacético) aquoso ou ácidos inorgânicos como HCI ou HBr. O material em solução aquosa é utilizado diretamente na próxima etapa. This step is aimed at deprotecting compound 15 to generate compound 16, which is (2S, 3S) -2-amino-1,3-dihydroxy-pent-4-yo, occurs in the presence of aqueous TFA (trifluoroacetic acid) or inorganic acids such as HCl or HBr. The aqueous solution material is used directly in the next step.

Etapa 5B Step 5B

Figure imgf000014_0002
Composto 16 Composto 17
Figure imgf000014_0002
Compound 16 Compound 17

Solução aquosa do composto 16 é diazotizada em presença de HBr e KBr, para obter o composto 17: (2S,3S)-2-bromo-l,3-diidróxi-pent-4-ino. O grupo amino é convertido inicialmente à fração diazo, que por sua vez é prontamente deslocada por ânions bromo. O composto 17 é recuperado por extração em solventes orgânicos. Etapa 6B Aqueous solution of compound 16 is diazotized in the presence of HBr and KBr to obtain compound 17: (2S, 3S) -2-bromo-1,3-dihydroxy-pent-4-yn. The amino group is initially converted to the diazo moiety, which in turn is readily displaced by bromine anions. Compound 17 is recovered by extraction in organic solvents. Step 6B

Figure imgf000014_0003
Composto 17 Composto 18
Figure imgf000014_0003
Compound 17 Compound 18

O composto 17 é dissolvido em solvente adequado, por exemplo, mistura de acetona e 2,2-dimetóxipropano e tratado com quantidade catalítica de ácido sulfônico ou BF3 eterato, resultando um composto 18: (2S,3S)-2-bromo-1.3-diidróxi-pent-4-ino acetonida. Compound 17 is dissolved in a suitable solvent, for example mixture of acetone and 2,2-dimethoxypropane and treated with catalytic amount of sulfonic acid or BF 3 etherate, resulting in compound 18: (2S, 3S) -2-bromo-1,3 -dihydroxy-pent-4-yne acetonide.

Etapa 7B Step 7B

Figure imgf000015_0001
Figure imgf000015_0001

Composto 18 Composto 19 Compound 18 Compound 19

Nesta etapa, para chegar ao composto 19 na sua forma ileto, após proteção do acetileno com TMS, o composto 18 é reagido com trifenilfosfina para formar o sal trifenilfosfônio. Para formar o reagente de Wittig, o sal fosfônio é suspenso em solvente adequado, como dietil éter ou THF e tratado com base forte, por exemplo, terc-butóxido de potássio, butil-lítio ou fenil-lítio. In this step, to reach compound 19 in its ylide form, after protection of acetylene with TMS, compound 18 is reacted with triphenylphosphine to form the triphenylphosphonium salt. To form Wittig's reagent, the phosphonium salt is suspended in a suitable solvent such as diethyl ether or THF and treated with a strong base, for example potassium tert-butoxide, butyllithium or phenyl lithium.

O homem da técnica, a partir dos ensinamentos aqui contidos, saberá propor realizações de maneiras não expressamente previstas aqui, mas com função e resultado, em cada etapa, da mesma natureza, estando assim tais realizações englobadas pelas reivindicações anexas.  The person skilled in the art, from the teachings herein, will know how to propose embodiments in ways not expressly provided herein, but with function and result, at each stage, of the same nature, and thus such embodiments are encompassed by the appended claims.

Claims

REIVINDICAÇÕES 1. Método de preparação de ingenol-5,20-acetonida caracterizado pelo fato de compreender as seguintes etapas:  1. Method of preparation of ingenol-5,20-acetonide characterized in that it comprises the following steps: - etapa 1: reagir o compost química abaixo  - Step 1: React the chemical compost below
Figure imgf000016_0001
denominado composto 9, com o composto dotado da estrutura química abaixo
Figure imgf000016_0001
compound 9, with the compound having the chemical structure below
Figure imgf000016_0002
denominado composto 19, em solução orgânica, em alta temperatura da ordem de 100 °C, em presença de base forte, particularmente terc-butóxido de potássio, obtendo-se um composto dotado da estrutura química abaixo
Figure imgf000016_0002
compound 19, in a high temperature organic solution of the order of 100 ° C, in the presence of a strong base, particularly potassium tert-butoxide, yielding a compound having the chemical structure below.
Figure imgf000016_0003
denominado intermediário 1.
Figure imgf000016_0003
referred to as intermediate 1.
- etapa 2: reagir o intermediário 1 com monóxido de carbono em presença de catalisador da reação de Pauson-Khand, obtendo-se um composto dotado da estrutura química abaixo - step 2: reacting intermediate 1 with carbon monoxide in the presence of Pauson-Khand reaction catalyst to obtain a compound with the structure chemistry below
Figure imgf000017_0001
denominado intermediário 2.
Figure imgf000017_0001
referred to as intermediate 2.
- etapa 3: efetuar uma diidroxilação do intermediário 2, seja via reação de osmilação catalisada com tetróxido de ósmio (Os04) em solução ou suportado em um polímero, seja via reação com periodato, ou peroximonosulfato de potássio, em presença de catalisador de rutênio ou cério, obtendo-se um composto dotado da estrutura química abaixo - step 3: perform a dihydroxylation of intermediate 2, either via osmillation catalyzed reaction with osmium tethoxide (Os0 4 ) in solution or supported on a polymer, either via reaction with periodate, or potassium peroxymonosulfate, in the presence of ruthenium catalyst or cerium, to obtain a compound with the chemical structure below.
Figure imgf000017_0002
denominado intermediário 3, que é então reagido com bis-imidazolil carbonato reagentes sililantes, obtendo-se um composto dotado da estrutura química abaixo
Figure imgf000017_0002
intermediate 3, which is then reacted with bisimidazolyl carbonate silylating reagents to give a compound having the chemical structure below.
Figure imgf000017_0003
denominado intermediário 4; - etapa 4: reagir o intermediário 4 com reagente de Grignard, particularmente brometo de metil magnésio, sob condições criogênicas, obtendo-se um composto dotado da estrutura química abaixo
Figure imgf000017_0003
called intermediate 4; - step 4: reacting intermediate 4 with Grignard reagent, particularly methyl magnesium bromide, under cryogenic conditions to give a compound having the chemical structure below.
Figure imgf000018_0001
Figure imgf000018_0001
denominado intermediário 5; called intermediate 5; - etapa 5: conduzir um rearranjo de pinacol do composto 5, em presença de catalisador adequado, particularmente fluoreto de boro eterato ou composto de organoalumínio, dando origem a um composto dotado da estrutura química abaixo  - step 5: conduct a pinacol rearrangement of compound 5, in the presence of a suitable catalyst, particularly boron etherate fluoride or organoaluminium compound, to give a compound having the chemical structure below.
Figure imgf000018_0002
Figure imgf000018_0002
denominado intermediário 6; called intermediate 6; - etapa 6: remover a proteção aos dióis eis introduzido na etapa 3, reagindo-se o intermediário 6 com meio adequado, particularmente uma base, TBAF ou hidrofluoreto de piridínio, dand genol-5,20-acetonida  - step 6: remove the diols protection introduced in step 3 by reacting intermediate 6 with a suitable medium, particularly a base, TBAF or pyridinium hydrofluoride, dand genol-5,20-acetonide.
Figure imgf000018_0003
ingenol-5,20-acetonida
Figure imgf000018_0003
ingenol-5,20-acetonide
2. Método de preparação de 3-etinil-3-hidroxi-4.7.7- trimetilbiciclo[4.1.0]heptano-2-carbaldeído caracterizado pelo fato de compreender as etapas de: 2. Method of preparation of 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde comprising the steps of: - etapa IA - cloração de (+)-3- careno, denominado composto 1
Figure imgf000019_0001
- stage IA - chlorination of (+) - 3-carene called compound 1
Figure imgf000019_0001
composto 1 compound 1 utilizando catalisador de radicais livres, particularmente N-cloro-succinamida (NCS) em presença de base, sob atmosfera de argônio, tendo como base do catalisador 1,4- diazabiciclo[2.2.2]octano, DMAP ou sílica gel, obtendo-se trans-4-cloro-3-careno, denominado composto 2
Figure imgf000019_0002
composto 2
using free radical catalyst, particularly N-chloro-succinamide (NCS) in the presence of base, under argon atmosphere, based on the catalyst 1,4-diazabicyclo [2.2.2] octane, DMAP or silica gel. trans-4-chloro-3-carene called compound 2
Figure imgf000019_0002
compound 2
- etapa 2A - ozonólise do composto 2 em solvente adequado, particularmente acetona aquosa, sob resfriamento, obtendo-se 4-cloro-7,7-dimetilbiciclo [4.1.0]heptano-3-ona), denominado composto 3
Figure imgf000019_0003
- step 2A - ozonolysis of compound 2 in a suitable solvent, particularly aqueous acetone, under cooling to give 4-chloro-7,7-dimethylbicyclo [4.1.0] heptane-3-one) called compound 3
Figure imgf000019_0003
composto 3  compound 3 - etapa 3A - hidrogenólise catalítica do composto 3, empregando-se catalisador adequado, particularmente paládio, sob pressão, obtendo-se 7,7- dimetilbiciclo[4.1.0]heptano-3-o posto 4
Figure imgf000019_0004
- step 3A - catalytic hydrogenolysis of compound 3 using a suitable catalyst, particularly palladium, under pressure to give 7,7-dimethylbicyclo [4.1.0] heptane-3-o
Figure imgf000019_0004
composto 4 - etapa 4A - reação do composto 4 com cloreto de TMS (trimetilsilila) e lítio bis(trimetilsilil)amida (LiHMDS ) em tetraidrofurano (THF) em condições criogênicas, obtendo-se um composto 5: tr [4.1.0]2-hepteno-3-ol compound 4 - Step 4A - Reaction of compound 4 with TMS (trimethylsilyl) and lithium bis (trimethylsilyl) amide (LiHMDS) chloride in tetrahydrofuran (THF) under cryogenic conditions to give compound 5: tr [4.1.0] 2-heptene -3-ol
Figure imgf000020_0001
composto 5
Figure imgf000020_0001
compound 5
- etapa 5A - hidroximetilação do composto 5, em formaldeído, em presença de Yb(OTf)3 (trifluorometanosulfonato de itérbio III), obtendo-se 2-hidroximetil-7,7- dimetilbiciclo[4.1.0]heptano-3-ona, denominado composto 6  - step 5A - hydroxymethylation of compound 5 in formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III) to give 2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one, called compound 6
Figure imgf000020_0002
composto 6
Figure imgf000020_0002
compound 6
- etapa 6A - metilação do composto 6, iniciada com a reação de proteção transitória do composto 6 com cloreto de trimetilsilila (TMS), formando-se um TMS enol, que é submetido a litiação com metil lítio, e subsequente reação em um vaso com metil iodato em condições criogênicas, obtendo-se 2-hidroximetil-4.7.7- trimetilbiciclo[4.1.0]heptano-3-ona, denominado composto 7  - step 6A - methylation of compound 6, initiated by the transient protective reaction of compound 6 with trimethylsilyl chloride (TMS), forming an enol TMS, which is subjected to lithium with lithium, and subsequent reaction in a pot with methyl iodate under cryogenic conditions to give 2-hydroxymethyl-4,7,7-trimethylbicyclo [4.1.0] heptane-3-one, called compound 7
Figure imgf000020_0003
composto 7
Figure imgf000020_0003
compound 7
- etapa 7A - reação do composto 7 com excesso de brometo de etinilmagnésio em solvente adequado, particularmente THF, em condições criogênicas, obtendo-se 3- etinil-2-hidroximetil-4.7.7-trimetilbiciclo [4.1.0] heptano-3-ol, denominado composto 8 - Step 7A - Reaction of compound 7 with excess ethinylmagnesium bromide in a suitable solvent, particularly THF, under cryogenic conditions to give 3-ethynyl-2-hydroxymethyl-4,7.7-trimethylbicyclo [4.1.0] heptane-3 ol, called compound 8
Figure imgf000021_0001
composto 8
Figure imgf000021_0001
compound 8
- etapa 8A - reação do composto 8 com l,l,l-triacetoxi-l,l-diidro-l,2-benziodoxol- 3(lH)-ona, reagente de Dess-Martin periodinano, obtendo-se etinil-3-hidroxi-4.7.7- trimetilbiciclo[4.1.0]heptano- omposto 9  - Step 8A - Reaction of compound 8 with 1,1,1-triacetoxy-1,1-dihydro-1,2-benziodoxol-3 (1H) -one, Dess-Martin periodinane reagent to give ethinyl-3- hydroxy-4.7.7-trimethylbicyclo [4.1.0] heptane-compound 9
Figure imgf000021_0002
Figure imgf000021_0002
Composto 9 9
3. Método de preparação de 3-etinil-3-hidroxi-4.7.7- trimetilbiciclo[4.1.0]heptano-2-carbaldeído, de acordo com a reivindicação 2, caracterizado pelo fato de que as ditas etapas 3A, 4A, 5A e 6A são substituídas pelas etapas 3AA, 4AA e 5AA, segundo as quais:  Method of preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde according to claim 2, characterized in that said steps 3A, 4A, 5A and 6A are replaced by steps 3AA, 4AA and 5AA, according to which: - etapa 3AA - reage-se o composto 3 com magnésio, gerando-se um reagente de Grignard, seguindo-se reação com iodeto de metila, com ou sem catalisador, particularmente NiBr2 ou CuCI2, obtendo-se 4-metil-7,7-dimetilbiciclo[4.1.0]heptano-3- ona, denominado composto 10 - Step 3AA - Compound 3 is reacted with magnesium, generating a Grignard reagent, followed by reaction with methyl iodide, with or without catalyst, particularly NiBr 2 or CuCl 2 , yielding 4-methyl-7. 7-dimethylbicyclo [4.1.0] heptane-3-one, called compound 10
Figure imgf000021_0003
Figure imgf000021_0003
composto 10 compound 10 - etapa 4AA - o composto 10 é reagido em solvente adequado, particularmente THF, com cloreto de TMS e lítio bis(trimetilsilil)amida (LiHDMS), em condições criogênicas, obtendo-se 4-metil-5-trimetilsilil 7,7-dimetilbiciclo[4.1.0]-2-hepteno-3-ol, denominado composto 11 - step 4AA - compound 10 is reacted in a suitable solvent, particularly THF, with TMS and lithium bis (trimethylsilyl) amide chloride (LiHDMS) under cryogenic conditions, 4-methyl-5-trimethylsilyl 7,7-dimethylbicyclo [4.1.0] -2-heptene-3-ol, called compound 11
Figure imgf000022_0001
composto 11
Figure imgf000022_0001
compound 11
- etapa 5AA - reação de hidroximetilação do composto 11 com formaldeído em presença de Yb(OTf)3, resultando o composto 7  - step 5AA - hydroxymethylation reaction of compound 11 with formaldehyde in the presence of Yb (OTf) 3, resulting compound 7
Figure imgf000022_0002
composto 7
Figure imgf000022_0002
compound 7
4. Método de preparação do composto 2,2-dimetil-4-etinil-5- trifenilfosforanilideno-l,3-dioxano, caracterizado por compreender as etapas de:  Method of preparing 2,2-dimethyl-4-ethynyl-5-triphenylphosphoranylidene-1,3-dioxane, comprising the steps of: - etapa 1B - reação do éster metílico de L-serina (composto 12) com anidrido de terc- butoxi carbonila em presença de trietilamina, resultando éster metílico de Boc-L- serina, o qual, em solvente adequado, particularmente acetona, é reagido com 2,2- dimetoxipropano em presença de quantidade catalítica de trifluoreto de boro eterato resultando em 3-Boc-2,2-dimetil-l,3-oxazolidina-4-carboxilato, denominado composto 13 - Step 1B - Reaction of L-serine methyl ester (compound 12) with tert-butoxycarbonyl anhydride in the presence of triethylamine, resulting in Boc-L-serine methyl ester which, in a suitable solvent, particularly acetone, is reacted. with 2,2-dimethoxypropane in the presence of catalytic amount of boron trifluoride etherate resulting in 3-Boc-2,2-dimethyl-1,3-oxazolidine-4-carboxylate called compound 13
Figure imgf000022_0003
Figure imgf000022_0003
Composto 13 - etapa 2B - reação do composto 13 com DIBAL (hidreto de diisobutilalumínio) resultando 3-Boc-2,2-dimetil-l,3-oxazolidina-4-formila, denominado composto 14, ou submete-se o composto 13 a uma redução, particularmente com hidreto de lítio alumínio ou boroidreto de lítio, seguida de oxidação, particularmente uma oxidação de Swern, ou via uso de um alvejante adequado, particularmente hipoclorito de sódio ou cálcio, em presença de catalisador o o composto 14 13 - step 2B - reacting compound 13 with DIBAL (diisobutyl aluminum hydride) resulting in 3-Boc-2,2-dimethyl-1,3-oxazolidine-4-formyl, called compound 14, or subject 13 to a reduction , particularly with lithium aluminum hydride or lithium borohydride, followed by oxidation, particularly a Swern oxidation, or via the use of a suitable bleach, particularly sodium or calcium hypochlorite, in the presence of catalyst or compound 14.
Figure imgf000023_0001
composto 14
Figure imgf000023_0001
compound 14
- etapa 3B - reação do composto 14 com brometo de magnésio acetileno ou lítio acetilida em meio solvente adequado, particularmente THF ou etil éter, obtendo-se Boc-(2S,3S)-2-Amino-l,3-diidroxi-pent-4-ina 1,2-acetal, denominado composto 15  - Step 3B - Reaction of compound 14 with magnesium acetylene bromide or lithium acetylide in a suitable solvent medium, particularly THF or ethyl ether to give Boc- (2S, 3S) -2-Amino-1,3-dihydroxypentyl 4-Aine 1,2-acetal, called compound 15
Figure imgf000023_0002
composto 15
Figure imgf000023_0002
compound 15
- etapa 4B - submeter o composto 15 a um meio ácido adequado, particularmente TFA (ácido trifluoroacético) aquoso ou ácidos inorgânicos como HCI ou HBr, obtendo-se (2S,3S)-2-amino-l,3-dihidroxi-pent-4-ino, denominado composto 16  - step 4B - subjecting compound 15 to a suitable acidic medium, particularly aqueous TFA (trifluoroacetic acid) or inorganic acids such as HCl or HBr, yielding (2S, 3S) -2-amino-1,3-dihydroxy-pentaphosphate. 4-ino, called compound 16
Figure imgf000023_0003
composto 16
Figure imgf000023_0003
compound 16
- etapa 5B - diazotização do composto 16 em presença de HBr e KBr, obtendo-se (2S,3S)-2-Bromo-l,3-diidróxi-pent-4-ino, denominado composto 17 - step 5B - diazotization of compound 16 in the presence of HBr and KBr, obtaining (2S, 3S) -2-Bromo-1,3-dihydroxy-pent-4-yne called compound 17
Figure imgf000024_0001
Figure imgf000024_0001
OH  OH composto 17 compound 17 - etapa 6B - dissolução do composto 17 em solvente adequado, particularmente mistura de acetona e 2,2-dimetóxipropano e tratamento com quantidade catalítica de ácido sulfônico ou BF3 eterato, obtendo-se (2S,3S)-2-bromo-l,3-diidróxi-pent-4-ino acetonida, denominado composto 18 - step 6B - dissolving compound 17 in a suitable solvent, particularly a mixture of acetone and 2,2-dimethoxypropane and treating with catalytic amount of sulfonic acid or BF 3 etherate to give (2S, 3S) -2-bromo-1, 3-dihydroxy-pent-4-yne acetonide, called compound 18
Figure imgf000024_0002
composto 18
Figure imgf000024_0002
compound 18
- etapa 7B - reagir o composto 18 com trifenilfosfina, seguindo-se suspensão do sal fosfônio formado em solvente adequado, particularmente dietil éter ou THF, e tratamento com base forte, particularmente terc-butóxido de potássio, butil-lítio ou fenil-lítio, resultando 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-l,3-dioxano, denominado composto 19  - step 7B - reacting compound 18 with triphenylphosphine, followed by suspension of the phosphonium salt formed in a suitable solvent, particularly diethyl ether or THF, and treatment with strong base, particularly potassium tert-butoxide, butyllithium or phenyl lithium, resulting 2,2-dimethyl-4-ethynyl-5-triphenylphosphoranylidene-1,3-dioxane, named compound 19
Figure imgf000024_0003
composto 19
Figure imgf000024_0003
compound 19
5. Composto intermediário, caracterizado por ser dotado da seguinte estrutura ca, denominado intermediário 1  5. Intermediate compound, characterized in that it has the following structure ca, called intermediate 1
Figure imgf000025_0001
Figure imgf000025_0001
Intermediário 1 Intermediate 1
6. Composto intermediário, caracterizado por ser dotado da seguinte estrutura química  6. Intermediate compound, characterized in that it has the following chemical structure
Figure imgf000025_0002
denominado intermediário 2.
Figure imgf000025_0002
referred to as intermediate 2.
7. Composto intermediário, caracterizado por ser dotado da seguinte estrutura química 7. Intermediate compound, characterized in that it has the following chemical structure
Figure imgf000026_0001
denominado intermediário 3.
Figure imgf000026_0001
called intermediate 3.
8. Composto intermediário, caracterizado por ser dotado da seguinte estrutura química  8. Intermediate compound, characterized in that it has the following chemical structure
Figure imgf000026_0002
denominado intermediário 4.
Figure imgf000026_0002
called intermediate 4.
9. Composto intermediário, caracterizado por ser dotado da seguinte estrutura química  9. Intermediate compound, characterized in that it has the following chemical structure
Figure imgf000026_0003
denominado intermediário 5.
Figure imgf000026_0003
called intermediate 5.
10. Composto intermediário, caracterizado pelo fato de ser dotado da seguinte estrutura química 10. Intermediate compound, characterized in that it has the following chemical structure
Figure imgf000027_0001
denominado intermediário 6.
Figure imgf000027_0001
called intermediate 6.
PCT/BR2015/050068 2015-06-03 2015-06-03 Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound Ceased WO2016191835A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/BR2015/050068 WO2016191835A1 (en) 2015-06-03 2015-06-03 Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2015/050068 WO2016191835A1 (en) 2015-06-03 2015-06-03 Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound

Publications (1)

Publication Number Publication Date
WO2016191835A1 true WO2016191835A1 (en) 2016-12-08

Family

ID=57439755

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2015/050068 Ceased WO2016191835A1 (en) 2015-06-03 2015-06-03 Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound

Country Status (1)

Country Link
WO (1) WO2016191835A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012010172A1 (en) * 2010-07-20 2012-01-26 Leo Pharma A/S A method of producing ingenol-3-angelate
WO2012085189A1 (en) * 2010-12-22 2012-06-28 Leo Pharma A/S Ingenol-3-acylates i
WO2012083953A1 (en) * 2010-12-22 2012-06-28 Leo Pharma A/S Ingenol-3-acylates iii and ingenol-3-carbamates
WO2014001215A2 (en) * 2012-06-26 2014-01-03 Leo Laboratories Limited 3-o-heteroaryl-ingenol

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012010172A1 (en) * 2010-07-20 2012-01-26 Leo Pharma A/S A method of producing ingenol-3-angelate
WO2012085189A1 (en) * 2010-12-22 2012-06-28 Leo Pharma A/S Ingenol-3-acylates i
WO2012083953A1 (en) * 2010-12-22 2012-06-28 Leo Pharma A/S Ingenol-3-acylates iii and ingenol-3-carbamates
WO2014001215A2 (en) * 2012-06-26 2014-01-03 Leo Laboratories Limited 3-o-heteroaryl-ingenol

Similar Documents

Publication Publication Date Title
Davis et al. Asymmetric oxidation of ester and amide enolates using new (camphorylsulfonyl) oxaziridines
EP3689881B1 (en) Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b
Ireland et al. An approach to the total synthesis of aplysiatoxin
Bantreil et al. Copper-Catalyzed Direct Synthesis of Benzamides from Alcohols and Amines.
ES2972431T3 (en) Procedure involving olefin cross metathesis
EP3297983B1 (en) Process for preparing a macrocyclic diketone
KR102793118B1 (en) Process for the preparation of carboprost and its tromethamine salt
Hara et al. Difluorination of alkenes with iodotoluene difluoride
CA2909209A1 (en) 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
CN108713015A (en) Preparation of macrolides
Casey et al. Stereochemistry of the degenerate metathesis of terminal alkenes-the nature of the chain-carrying metal-carbene complex
Zhang et al. An efficient cis-reduction of alkyne to alkene in the presence of a vinyl iodide: stereoselective synthesis of the C22–C31 fragment of leiodolide A
WO2016191835A1 (en) Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound
WO2008081191A1 (en) Improved method for the wittig reaction in the preparation of carboprost
WO2016191837A1 (en) Method for preparing ingenol-3-hexanoate, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, and method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane
WO2016191836A1 (en) Method for preparing ingenol-3-dodecanoate, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, and method for preparing 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane
Davies et al. Double diastereoselective SuperQuat glycolate aldol reactions: Application to the asymmetric synthesis of polyfunctionalised lactones
BR102014013462A2 (en) ingenol-5,20-acetonide preparation method, preparation method of 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde, preparation method of 2,2-dimethyl compound -4-ethynyl-5-triphenylphosphoranylidene-1,3-dioxane and intermediate
BR102014013459A2 (en) ingenol-3-dodecanoate preparation method, preparation method of 3-ethynyl-3-hydroxy-4,7.7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde and preparation method of 2,2-dimethyl-4-one ethinyl-5-triphenylphosphoranylidene-1,3-dioxane
BR102014013457A2 (en) ingenol-3-hexanoate preparation method, preparation method of 3-ethynyl-3-hydroxy-4,7.7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde and preparation method of 2,2-dimethyl-4 compound -etinyl-5-triphenylphosphoranylidene-1,3-dioxane
Hilt et al. Cobalt-catalysed hydrovinylation as the key step in a short synthesis of moenocinol
Xu et al. Synthesis of chiral heterocyclic compounds via zirconium-catalyzed asymmetric carboalumination of alkenes (ZACA reaction)
NO157414B (en) PROCEDURE FOR THE PREPARATION OF CARBOXYLIC ACIDS AND ESTERS THEREOF.
CN115181015A (en) Synthetic method of tri-substituted perfluoroalkylated ketene compounds
JP4910150B2 (en) A method for producing a β-fluoro (phenylsulfonyl) methyl adduct and a method for producing an optically active β-fluoromethylcarbonyl derivative.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15893553

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15893553

Country of ref document: EP

Kind code of ref document: A1